查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301040

生物芯片市场规模、份额和趋势分析报告：按类型（DNA 芯片、芯片实验室、细胞阵列、组织阵列、蛋白质芯片）、最终用途、地区、细分市场趋势，2023-2030 年

Biochip Market Size, Share & Trends Analysis Report, By Type (DNA Chips, Lab-on-Chip, Cell Arrays, Tissue Arrays, Protein Chips), By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

生物芯片市场增长和趋势

根据 Grand View Research, Inc. 最新报告，到 2030 年，全球生物芯片市场规模将达到 259.2 亿美元，预计将以年復合增长率为12.66%。

对药物发现和药物开发的需求不断增长，加上个性化医疗的采用，可能会促进该行业的增长。 此外，世界各地的生物技术公司越来越多地采用下一代测序，这也推动了产品需求。 例如，2021 年 12 月，雅培的 i-STAT TBI 血浆测试获得了 CE 标誌，这是一种便携式创伤性脑损伤 (TBI) 血液分析仪。 因此，该公司被允许扩大在欧盟（EU）的业务。 测序技术的创新使研究人员能够将 DNA 分子解码到完整人类基因组的水平。

Thermo Fisher Scientific 的 Ion Torrent 芯片是基于合成测序技术的几种技术之一。 该芯片是新一代测序 (NGS) 技术的进步，使大规模并行测序对于任何实验室来说都具有成本效益。 因此，开发生物芯片以增强NGS应用预计将支持行业增长。 同样，越来越多的政府举措促进国内生物芯片生产可能会支持未来几年的增长。 这一战略举措旨在满足当地对我们产品的需求和供应。 例如，2022 年 7 月，SiPhox, Inc. 从 Baker Polito 政府获得了价值 681,631 美元的赠款。

这笔资金将加速大规模生产可插拔光子生物芯片的製造设施的开发。 预计生物芯片的月产量将从约100个加速至约5,000个，以满足药物发现、疫苗开发和分布式诊断等生物技术领域不断增长的需求。 预计此类投资将在未来几年补充行业增长。 预计 COVID-19 大流行将对预测期内的行业增长产生积极影响。 多家公司共同努力开发创新解决方案来应对这一流行病。 例如，2020 年 3 月，SkyWater Technology 宣布与华大智造合作，为 COVID-19 测序提供必要的组件，包括微流控 MEMS 设备。

对个性化医疗日益增长的需求很可能成为未来几年该行业的关键应用领域。 随着生物芯片已成为分子诊断的重要组成部分，它们在即时诊断中的使用预计将促进个性化药物的开发。 此外，使用微阵列进行基因表达谱分析有望推进基于分子分类的个体化癌症治疗。 然而，生产生物芯片的成本相当高，对最终用户来说价格昂贵。 例如，Josep Carreras 白血病研究所 (IJC) 为研究人员提供微阵列。 GeneChip Human Gene 2.0 ST 全转录本表达分析和新鲜样品的分析成本为 456 美元至 593 美元。

生物芯片市场报告亮点

  • 由于对快速、准确的癌症检测的高需求，DNA 芯片类型细分市场在 2022 年占据了最大的收入份额。
  • 由于生物芯片有助于降低药物发现和开发的总体成本，芯片实验室药物发现应用领域预计将在预测期内快速增长。
  • 由于对个性化药物的需求以及药物发现和开发的增加，生物技术和製药公司的最终用户部门将在 2022 年获得大量收入份额。
  • 由于高额研发投资以及通过风险投资和生物芯片应用开发为初创公司提供资金，北美在 2022 年占据了最大的收入份额。
  • 预计 2023 年至 2030 年，亚太地区将以最快的复合年增长率增长。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 段定义
  • 信息获取
  • 信息或数据分析
  • 市场范围和细分定义
  • 市场模式
    • 按公司市场份额进行市场调查
    • 区域分析

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第三章市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 行业分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 的影响分析

第 4 章按类型划分的业务分析

  • 生物芯片市场：类型变化分析
  • DNA芯片
    • DNA 芯片市场，2018-2030 年（百万美元）
    • 癌症诊断和治疗
    • 基因表达
    • SNP 基因分型
    • 基因组学
    • 药物发现
    • 农业生物技术
    • 其他
  • 蛋白质芯片
    • 2018-2030 年蛋白质芯片市场（百万美元）
    • 蛋白质组学
    • 表达分析
    • 诊断
    • 高温超导
    • 药物发现
    • 其他
  • 芯片实验室
    • 芯片实验室市场，2018-2030 年（百万美元）
    • 基因组学
    • IVD 和 POC
    • 蛋白质组学
    • 药物发现
    • 其他
  • 组织阵列
    • 2018-2030 年组织芯片市场（百万美元）
  • 组织阵列
    • 2018-2030 年组织芯片市场（百万美元）

第 5 章最终用途业务分析

  • 生物芯片市场：最终用途变化分析
  • 学术研究机构
    • 2018-2030 年学术研究市场（百万美元）
  • 製药和生物技术公司
    • 2018-2030 年製药和生物技术企业市场（百万美元）
  • 医院和诊断中心
    • 2018-2030 年医院和诊断中心市场（百万美元）
  • 其他
    • 其他市场，2018-2030 年（百万美元）

第 6 章区域业务分析

  • 2022 年和 2030 年按地区划分的生物芯片市场份额
  • 北美
    • SWOT分析
    • 2018-2030 年北美生物芯片市场（百万美元）
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 2018-2030 年欧洲生物芯片市场（百万美元）
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT分析
    • 2018-2030 年亚太生物芯片市场（百万美元）
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 泰国
    • 韩国
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲生物芯片市场，2018-2030 年（百万美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • SWOT分析
    • MEA 生物芯片市场，2018-2030 年（百万美元）
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第7章竞争格局

  • 公司分类
  • 战略规划
  • 2022 年公司市场份额分析
  • 公司简介/列表
    • Thermo Fisher Scientific, Inc
    • Agilent Technologies, Inc.
    • PerkinElmer Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools
    • GE Healthcare
    • LI-COR, Inc.
    • QIAGEN
    • Randox Laboratories Ltd
Product Code: GVR-1-68038-077-4

Biochips Market Growth & Trends

The global biochips market size is expected to reach USD 25.92 billion by 2030, registering a CAGR of 12.66% during the forecast period, according to a new report by Grand View Research, Inc. The rising requirement for drug discovery and development coupled with the adoption of personalized medicine is likely to favor the industry's growth. Furthermore, the rise in the implementation of next-generation sequencing by biotechnology companies around the globe is pushing product demand. For instance, in December 2021, Abbott received CE Mark for the i-STAT TBI Plasma test, a portable analyzer for Traumatic Brain Injury (TBI) blood. Hence, the company is permitted to expand its footprint in the European Union. The innovation in sequencing techniques has allowed researchers to decode DNA molecules up to the level of the complete human genome.

Ion Torrent chip by Thermo Fisher Scientific is one of the technologies based on sequencing by the technique of synthesis. The chip is an advancement in the Next-Generation Sequencing (NGS) technology that makes massively parallel sequencing cost-effective for every lab. Hence, the development of biochips to enhance the NGS application is anticipated to support the growth of the industry. Similarly, increasing government-based initiatives to promote the domestic production of biochips is likely to support the growth in the coming years. This strategic initiative is to match the local demand for the product with the supply. For instance, in July 2022, SiPhox, Inc. received a grant worth USD 681,631 from the Baker-Polito Administration.

The financial support is to accelerate the development of a manufacturing facility for the mass production of pluggable photonic biochips. It is estimated to accelerate the output to around 5,000 biochips per month from around 100 per month to match the rising demand from biotech segments including drug discovery, vaccine development, and distributed diagnostics. Such investments are likely to supplement the industry growth in the coming years. The COVID-19 pandemic is estimated to have a positive impact on industry growth during the forecasted period. Various companies collaborated to develop innovative solutions to deal with the pandemic. For instance, in March 2020, SkyWater Technology announced the collaboration with MGI, to supply essential components for COVID-19 sequencing, including microfluidic MEMS devices.

The growing requirement for personalized medicine is likely to become a key application area for the industry in the coming years. Since biochip is emerging as an important component in molecular diagnostics, their use in point-of-care diagnostics is anticipated to smooth the development of personalized medicines. In addition, gene expression profiling through microarrays is expected to enhance the progress of personalized treatment for cancer based on molecular classification. However, the cost involved in the manufacturing of biochips is considerably high, resulting in high pricing for end-users. For instance, Josep Carreras Leukaemia Research Institute (IJC) provides microarray to researchers. The cost of GeneChip Human Gene 2.0 ST for whole-transcript expression analysis & profiling ranges from USD 456 to 593 for fresh samples.

Biochips Market Report Highlights

  • The DNA chips type segment accounted for the largest revenue share in 2022 due to the high demand for rapid and accurate detection of cancer
  • The drug discovery application segment for lab-on-chip is anticipated to grow at a faster rate during the forecast period as the biochip helps lower the overall cost of drug discovery & development
  • The biotechnology and pharmaceutical companies end-user segment captured a significant revenue share in 2022 due to the need for personalized medicines along with the increasing drug discovery & development
  • North America held the largest revenue share in 2022 owing to high R&D investment coupled with the accessibility of capital through venture capitalists for startups and the application development of biochips in the region
  • Asia Pacific is projected to register the fastest CAGR from 2023 to 2030 owing to various initiatives by local governments to promote domestic product manufacturing

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
  • 1.2. Information Procurement
  • 1.3. Information Or Data Analysis
  • 1.4. Market Scope & Segment Definition
  • 1.5. Market Model
    • 1.5.1. Market Study, By Company Market Share
    • 1.5.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in adoption of next-generation sequencing
      • 3.2.1.2. Growing R&D in proteomics and genomics
      • 3.2.1.3. Presence of an extensive drug-development pipeline
      • 3.2.1.4. Increasing adoption of personalized medicine
      • 3.2.1.5. Rapid technological advances in biochip technology
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of manufacturing
      • 3.2.2.2. Lack of knowledge regarding biochips
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Biochip Market: Type Movement Analysis
  • 4.2. DNA Chips
    • 4.2.1. DNA Chips Market, 2018 - 2030 (USD Million)
    • 4.2.2. Cancer Diagnosis and Treatment
      • 4.2.2.1. Cancer Diagnosis and Treatment Market, 2018 - 2030 (USD Million)
    • 4.2.3. Gene Expression
      • 4.2.3.1. Gene Expression Market, 2018 - 2030 (USD Million)
    • 4.2.4. SNP Genotyping
      • 4.2.4.1. SNP Genotyping Market, 2018 - 2030 (USD Million)
    • 4.2.5. Genomics
      • 4.2.5.1. Genomics Market, 2018 - 2030 (USD Million)
    • 4.2.6. Drug Discovery
      • 4.2.6.1. Drug Discovery Market, 2018 - 2030 (USD Million)
    • 4.2.7. Agricultural Biotechnology
      • 4.2.7.1. Agricultural Biotechnology Market, 2018 - 2030 (USD Million)
    • 4.2.8. Others
      • 4.2.8.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. Protein Chips
    • 4.3.1. Protein Chips Market, 2018 - 2030 (USD Million)
    • 4.3.2. Proteomics
      • 4.3.2.1. Proteomics Market, 2018 - 2030 (USD Million)
    • 4.3.3. Expression Profiling
      • 4.3.3.1. Expression Profiling Market, 2018 - 2030 (USD Million)
    • 4.3.4. Diagnostics
      • 4.3.4.1. Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.5. HTS
      • 4.3.5.1. HTS Market, 2018 - 2030 (USD Million)
    • 4.3.6. Drug Discovery
      • 4.3.6.1. Drug Discovery Market, 2018 - 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. Lab-on- chips
    • 4.4.1. Lab-on- Chips Market, 2018 - 2030 (USD Million)
    • 4.4.2. Genomics
      • 4.4.2.1. Genomics Market, 2018 - 2030 (USD Million)
    • 4.4.3. IVD & POC
      • 4.4.3.1. IVD & POC Market, 2018 - 2030 (USD Million)
    • 4.4.4. Proteomics
      • 4.4.4.1. Proteomics Market, 2018 - 2030 (USD Million)
    • 4.4.5. Drug Discovery
      • 4.4.5.1. Drug DiscoveryMarket, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Tissue Arrays
    • 4.5.1. Tissue Arrays Market, 2018 - 2030 (USD Million)
  • 4.6. Cell Arrays
    • 4.6.1. Cell Arrays Market, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Biochip Market: End-Use Movement Analysis
  • 5.2. Academic and Research Institutes
    • 5.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 5.3. Pharmaceutical & Biotechnology Companies
    • 5.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.4. Hospitals and Diagnostics Centers
    • 5.4.1. Hospitals and Diagnostics Centers Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Biochip Market Share By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. SWOT Analysis
    • 6.2.2. North America Biochip Market, 2018 - 2030 (USD Million)
    • 6.2.3. U.S.
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. U.S. Biochip Market, 2018 - 2030 (USD Million)
    • 6.2.4. Canada
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Target Disease Prevalence
      • 6.2.4.3. Competitive Scenario
      • 6.2.4.4. Canada Biochip Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. SWOT Analysis
    • 6.3.2. Europe Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. UK Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Germany Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.5. France
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. France Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.6. Italy
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Italy Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.7. Spain
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Spain Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.8. Denmark
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Denmark Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.9. Sweden
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Sweden Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.10. Norway
      • 6.3.10.1. Key Country Dynamics
      • 6.3.10.2. Target Disease Prevalence
      • 6.3.10.3. Competitive Scenario
      • 6.3.10.4. Norway Biochip Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. SWOT Analysis
    • 6.4.2. Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Japan Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.4. China
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. China Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.5. India
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. India Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Australia Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Thailand Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.8. South Korea
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Target Disease Prevalence
      • 6.4.8.3. Competitive Scenario
      • 6.4.8.4. South Korea Biochip Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. SWOT Analysis
    • 6.5.2. Latin America Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.3. Brazil
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Brazil Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Mexico Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.5. Argentina
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Argentina Biochip Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. SWOT Analysis
    • 6.6.2. MEA Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. South Africa Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.4. Saudi Arabia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.5. UAE
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. UAE Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.6. Kuwait
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Kuwait Biochip Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Thermo Fisher Scientific, Inc
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Agilent Technologies, Inc.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. PerkinElmer Inc.
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Illumina, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Bio-Rad Laboratories, Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Standard BioTools
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. GE Healthcare
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. LI-COR, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. QIAGEN
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Randox Laboratories Ltd
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 5 Global Biochip Market, By End-Use, 2018 - 2030 (USD Million
  • TABLE 6 Global Biochip Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 7 North America Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 8 North America Biochip Market, By Type, 2018 - 2030 (USD Million),
  • TABLE 9 North America Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 12 Canada Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 13 Canada Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 14 Europe Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 15 Europe Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 16 Europe Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 17 UK Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 18 UK Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 19 Germany Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 20 Germany Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 21 France Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 22 France Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 23 Spain Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 24 Spain Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 25 Italy Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 26 Italy Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 27 Denmark Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 28 Denmark Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 29 Norway Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 30 Norway Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 31 Sweden Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 32 Sweden Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 33 Asia Pacific Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 34 Asia Pacific Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 35 Asia Pacific Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 36 China Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 37 China Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 38 Japan Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 39 Japan Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 40 India Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 41 India Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 42 South Korea Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 43 South Korea Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 44 Australia Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 45 Australia Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 46 Thailand Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 47 Thailand Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 48 Latin America Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 49 Latin America Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 50 Latin America Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 51 Brazil Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 52 Brazil Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 53 Mexico Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 54 Mexico Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 55 Argentina Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 56 Argentina Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 57 MEA Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 58 MEA Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 59 MEA Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 60 South Africa Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 61 South Africa Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 62 UAE Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 63 UAE Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 64 Saudi Arabia Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 65 Saudi Arabia Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 66 Kuwait Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 67 Kuwait Biochip Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 biochip market segmentation.
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 PESTEL analysis
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Global biochip market: Type movement analysis
  • FIG. 15 Global biochip market, for DNA chips, 2018 - 2030 (USD Million)
  • FIG. 16 Global biochip market, for cancer diagnosis and treatment, 2018 - 2030 (USD Million)
  • FIG. 17 Global biochip market, for gene expression, 2018 - 2030 (USD Million)
  • FIG. 18 Global biochip market, for SNP genotyping, 2018 - 2030 (USD Million)
  • FIG. 19 Global biochip market, for genomics, 2018 - 2030 (USD Million)
  • FIG. 20 Global biochip market, for drug discovery, 2018 - 2030 (USD Million)
  • FIG. 21 Global biochip market, for agricultural biotechnology, 2018 - 2030 (USD Million)
  • FIG. 22 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 23 Global biochip market, for protein chips, 2018 - 2030 (USD Million)
  • FIG. 24 Global biochip market, for proteomics, 2018 - 2030 (USD Million)
  • FIG. 25 Global biochip market, for expression profiling, 2018 - 2030 (USD Million)
  • FIG. 26 Global biochip market, for diagnostics, 2018 - 2030 (USD Million)
  • FIG. 27 Global biochip market, for HTS, 2018 - 2030 (USD Million)
  • FIG. 28 Global biochip market, for drug discovery, 2018 - 2030 (USD Million)
  • FIG. 29 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 30 Global biochip market, for lab-on-chip, 2018 - 2030 (USD Million)
  • FIG. 31 Global biochip market, for genomics, 2018 - 2030 (USD Million)
  • FIG. 32 Global biochip market, for IVD& POC, 2018 - 2030 (USD Million)
  • FIG. 33 Global biochip market, for proteomics, 2018 - 2030 (USD Million)
  • FIG. 34 Global biochip market, for drug discovery, 2018 - 2030 (USD Million)
  • FIG. 35 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 36 Global biochip market, for tissue arrays, 2018 - 2030 (USD Million)
  • FIG. 37 Global biochip market, for cell arrays, 2018 - 2030 (USD Million)
  • FIG. 38 Global biochip market: End-Use movement analysis
  • FIG. 39 Global biochip market, for academic and research institutes, 2018 - 2030 (USD Million)
  • FIG. 40 Global biochip market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • FIG. 41 Global biochip market, for hospitals and diagnostics centers, 2018 - 2030 (USD Million)
  • FIG. 42 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 43 Regional marketplace: Key takeaways
  • FIG. 44 Regional outlook, 2022 & 2030
  • FIG. 45 Global biochip market: Region movement analysis
  • FIG. 46 North America biochip market, 2018 - 2030 (USD Million)
  • FIG. 47 U.S. biochip market, 2018 - 2030 (USD Million)
  • FIG. 48 Canada biochip market, 2018 - 2030 (USD Million)
  • FIG. 49 Europe biochip market, 2018 - 2030 (USD Million)
  • FIG. 50 Germany biochip market, 2018 - 2030 (USD Million)
  • FIG. 51 UK biochip market, 2018 - 2030 (USD Million)
  • FIG. 52 France biochip market, 2018 - 2030 (USD Million)
  • FIG. 53 Italy biochip market, 2018 - 2030 (USD Million)
  • FIG. 54 Spain biochip market, 2018 - 2030 (USD Million)
  • FIG. 55 Denmark biochip market, 2018 - 2030 (USD Million)
  • FIG. 56 Sweden biochip market, 2018 - 2030 (USD Million)
  • FIG. 57 Norway biochip market, 2018 - 2030 (USD Million)
  • FIG. 58 Asia Pacific biochip market, 2018 - 2030 (USD Million)
  • FIG. 59 Japan biochip market, 2018 - 2030 (USD Million)
  • FIG. 60 China biochip market, 2018 - 2030 (USD Million)
  • FIG. 61 India biochip market, 2018 - 2030 (USD Million)
  • FIG. 62 Australia biochip market, 2018 - 2030 (USD Million)
  • FIG. 63 South Korea biochip market, 2018 - 2030 (USD Million)
  • FIG. 64 Thailand biochip market, 2018 - 2030 (USD Million)
  • FIG. 65 Latin America biochip market, 2018 - 2030 (USD Million)
  • FIG. 66 Brazil biochip market, 2018 - 2030 (USD Million)
  • FIG. 67 Mexico biochip market, 2018 - 2030 (USD Million)
  • FIG. 68 Argentina biochip market, 2018 - 2030 (USD Million)
  • FIG. 69 Middle East and Africa biochip market, 2018 - 2030 (USD Million)
  • FIG. 70 South Africa biochip market, 2018 - 2030 (USD Million)
  • FIG. 71 Saudi Arabia biochip market, 2018 - 2030 (USD Million)
  • FIG. 72 UAE biochip market, 2018 - 2030 (USD Million)
  • FIG. 73 Kuwait biochip market, 2018 - 2030 (USD Million)